These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24468190)

  • 1. Dietary flavonoids fisetin and myricetin: dual inhibitors of Plasmodium falciparum falcipain-2 and plasmepsin II.
    Jin H; Xu Z; Cui K; Zhang T; Lu W; Huang J
    Fitoterapia; 2014 Apr; 94():55-61. PubMed ID: 24468190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrido[1,2-a]pyrimidin-4-ones as antiplasmodial falcipain-2 inhibitors.
    Mane UR; Li H; Huang J; Gupta RC; Nadkarni SS; Giridhar R; Naik PP; Yadav MR
    Bioorg Med Chem; 2012 Nov; 20(21):6296-304. PubMed ID: 23040894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region.
    Gambini L; Rizzi L; Pedretti A; Taglialatela-Scafati O; Carucci M; Pancotti A; Galli C; Read M; Giurisato E; Romeo S; Russo I
    PLoS One; 2015; 10(11):e0142509. PubMed ID: 26566224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Falcipain-2 inhibition by suramin and suramin analogues.
    Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
    Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
    Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial evaluation of copper(II) nanohybrid solids: inhibition of plasmepsin II, a hemoglobin-degrading malarial aspartic protease from Plasmodium falciparum.
    Mohapatra SC; Tiwari HK; Singla M; Rathi B; Sharma A; Mahiya K; Kumar M; Sinha S; Chauhan SS
    J Biol Inorg Chem; 2010 Mar; 15(3):373-85. PubMed ID: 19946719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downstream effects of haemoglobinase inhibition in Plasmodium falciparum-infected erythrocytes.
    Naughton JA; Nasizadeh S; Bell A
    Mol Biochem Parasitol; 2010 Oct; 173(2):81-7. PubMed ID: 20478341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
    Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
    J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial activity of HIV-1 protease inhibitor in chromone series.
    Lerdsirisuk P; Maicheen C; Ungwitayatorn J
    Bioorg Chem; 2014 Dec; 57():142-147. PubMed ID: 25462990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-activity-relationship studies of thiazolidinediones as antiplasmodial inhibitors of the Plasmodium falciparum cysteine protease falcipain-2.
    Sharma RK; Younis Y; Mugumbate G; Njoroge M; Gut J; Rosenthal PJ; Chibale K
    Eur J Med Chem; 2015 Jan; 90():507-18. PubMed ID: 25486422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
    Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. QSAR, docking and ADMET studies of artemisinin derivatives for antimalarial activity targeting plasmepsin II, a hemoglobin-degrading enzyme from P. falciparum.
    Qidwai T; Yadav DK; Khan F; Dhawan S; Bhakuni RS
    Curr Pharm Des; 2012; 18(37):6133-54. PubMed ID: 22670592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological activities of novel artemisinin derivatives as cysteine protease falcipain-2 inhibitors.
    Liu Y; Lu WQ; Cui KQ; Luo W; Wang J; Guo C
    Arch Pharm Res; 2012 Sep; 35(9):1525-31. PubMed ID: 23054708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum: new molecular targets with potential for antimalarial drug development.
    Gardiner DL; Skinner-Adams TS; Brown CL; Andrews KT; Stack CM; McCarthy JS; Dalton JP; Trenholme KR
    Expert Rev Anti Infect Ther; 2009 Nov; 7(9):1087-98. PubMed ID: 19883329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic compounds from an in house library as inhibitors of falcipain-2 from Plasmodium falciparum.
    Bertoldo JB; Chiaradia-Delatorre LD; Mascarello A; Leal PC; Cordeiro MN; Nunes RJ; Sarduy ES; Rosenthal PJ; Terenzi H
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):299-307. PubMed ID: 24964346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insight into selectivity of peptidomimetic inhibitors with modified statine core for plasmepsin II of Plasmodium falciparum over human cathepsin D.
    Dali B; Keita M; Megnassan E; Frecer V; Miertus S
    Chem Biol Drug Des; 2012 Apr; 79(4):411-30. PubMed ID: 22129033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.